Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | PAM | P19021 | 2/20 | 0.57 |
| ▸ | CES2 | O00748 | 3/20 | 0.56 |
| ▸ | CES1 | P23141 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 6/20 | 0.54 |
| ▸ | PPARD | Q03181 | 6/20 | 0.54 |
| ▸ | PPARA | Q07869 | 6/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.54 |
| ▸ | TSHR | P16473 | 4/20 | 0.54 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.54 |
| ▸ | TLR2 | O60603 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | FABP4 | P15090 | 2/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.54 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28237874 | 1.00 | DGKA (0.64) | DGKALMNAALDH1A1PAMCES2 | |
| SCHEMBL8985011 | 1.00 | DGKA (0.64) | DGKALMNAALDH1A1PAMCES2 | |
| SCHEMBL1659992 | 1.00 | DGKA (0.64) | DGKALMNAALDH1A1PAMCES2 | |
| SCHEMBL27093014 | 1.00 | DGKA (0.64) | DGKALMNAALDH1A1PAMCES2 | |
| SCHEMBL8406703 | 1.00 | DGKA (0.64) | DGKALMNAALDH1A1PAMCES2 | |
| SCHEMBL20994176 | 1.00 | DGKA (0.64) | DGKALMNAALDH1A1PAMCES2 | |
| SCHEMBL152597 | 0.97 | DGKA (0.67) | DGKALMNAALDH1A1PAMCES2 | |
| SCHEMBL15527970 | 0.97 | DGKA (0.67) | DGKALMNAALDH1A1PAMCES2 | |
| SCHEMBL2727904 | 0.97 | DGKA (0.67) | DGKALMNAALDH1A1PAMCES2 | |
| Dodecanoic Anhydride SCHEMBL468394 | 0.97 | DGKA (0.67) | DGKALMNAALDH1A1PAMCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240052099-A1 | POLYANHYDRIDES AND METHODS OF MAKING SAME | POLYGENE LTD. (IL) | 2024-02-15 | — | — | US | disclosed |
| CN-116419764-A | Polyanhydride and preparation method thereof | 多基因有限公司 | 2023-07-11 | — | — | CN | disclosed |
| EP-4192905-A1 | POLYANHYDRIDES AND METHODS OF MAKING SAME | Polygene Ltd. (IL) | 2023-06-14 | — | — | EP | disclosed |
| WO-2022029783-A1 | POLYANHYDRIDES AND METHODS OF MAKING SAME | POLYGENE LTD. (IL) | 2022-02-10 | — | — | WO | disclosed |
| EP-3697775-A1 | RET9 AND VEGFR2 INHIBITORS | Kala Pharmaceuticals, Inc. (US) | 2020-08-26 | — | — | EP | disclosed |
| EP-3487945-A1 | USE OF POLYOLESTERS FOR PRODUCING POROUS PLASTIC COATINGS | Evonik Degussa GmbH (DE) | 2019-05-29 | — | — | EP | disclosed |
| WO-2019079747-A1 | RET9 AND VEGFR2 INHIBITORS | KALA PHARMACEUTICALS, INC. (US) | 2019-04-25 | — | — | WO | disclosed |
| CN-104751941-B | Heat-curing type conductive paste | 株式会社则武 | 2018-04-13 | — | — | CN | disclosed |
| EP-2489653-B1 | METHOD FOR PRODUCING REDUCED COENZYME Q10 AND COMPOSITION COMPRISING SAME | KANEKA CORP (JP) | 2017-11-29 | — | — | EP | disclosed |
| EP-3131975-A1 | REDUCED MOISTURE PICKUP IN POLYOL-CONTAINING MINERAL FILLER PRODUCTS | Omya International AG (CH) | 2017-02-22 | — | — | EP | disclosed |
| WO-2010130794-A1 | 5-PYRIDIN-3-YL-1,3-DIHYDRO-INDOL-2-ON DERIVATIVES AND THEIR USE AS MODULATORS OF ALDOSTERONE SYNTHASE AND/OR CYP11B1 | NOVARTIS AG (CH) | 2010-11-18 | — | — | WO | disclosed |
| EP-2218446-A1 | METHOD FOR PRODUCING MICROCAPSULE USING SOLID FAT | Kaneka Corporation (JP) | 2010-08-18 | — | — | EP | disclosed |
| US-20100168249-A1 | COMPOSITION CONTAINING REDUCED COENZYME Q10, AND METHOD FOR STABILIZING THE COMPOSITION | KANEKA CORPORATION (JP) | 2010-07-01 | — | — | US | disclosed |
| CN-1444582-A | Heterocyclic compound, their preparation and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-09-24 | — | — | CN | disclosed |
| EP-0652206-B1 | Fluorine-containing carboxylic acid amine salt and a magnetic recording medium with the same thereon | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 1999-07-14 | — | — | EP | disclosed |
| US-5604032-A | LUBRICANTS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1997-02-18 | — | — | US | disclosed |
| WO-1996022270-A1 | BIOPOLYMERS DERIVED FROM HYDROLYZABLE DIACID FATS | YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1996-07-25 | — | — | WO | disclosed |
| US-5486591-A | Biopolymers derived from hydrolyzable diacid fats | YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1996-01-23 | — | — | US | disclosed |
| US-5473103-A | POLYESTERS, POLYANHYDRIDES | YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1995-12-05 | — | — | US | disclosed |
| EP-0652206-A2 | Fluorine-containing carboxylic acid amine salt and a magnetic recording medium with the same thereon | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1995-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240052099-A1 | POLYANHYDRIDES AND METHODS OF MAKING SAME | PUF60, DDOST, PARG | DGKA 1830/4885LMNA 2362/4885ALDH1A1 2712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.